EPH131 Estimation of the Population of Patients Eligible for Pirtobrutinib after Covalent Bruton Tyrosine Kinase Inhibitor (CBTKI) Discontinuation in the United States
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1013
https://www.valueinhealthjournal.com/article/S1098-3015(23)01113-0/fulltext
Title :
EPH131 Estimation of the Population of Patients Eligible for Pirtobrutinib after Covalent Bruton Tyrosine Kinase Inhibitor (CBTKI) Discontinuation in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01113-0&doi=10.1016/j.jval.2023.03.1013
First page :
Section Title :
Open access? :
No
Section Order :
10458